Results 271 to 280 of about 78,807 (341)

Editorial: Dystonia and tremor

Dystonia
Pattamon Panyakaew, Aparna Wagle Shukla
doaj   +1 more source

Self-Reported Dystonia and Dystonia on Neurological Examination: Prevalence and Concordance across Time in a Prospectively Followed Essential Tremor Cohort.

Neuroepidemiology
Guy TO, Berry DS, Sharma VD, Louis ED.
europepmc   +1 more source

Mapping neurological symptoms and muscle tension representations in impaired gray matter volume of Wilson disease. [PDF]

Front Neurol
Ding Y, Cao K, Yang W, Hu S, Zhang J, Yang Y, Zhang X.   +6 more
europepmc   +1 more source

Reply: Comorbid Obsessive Compulsive Disorder in Tourette's Syndrome: Questioning its Impact

Movement Disorders Clinical Practice, EarlyView.
Yasamin Mahjoub, Davide Martino
wiley   +1 more source

Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis

Movement Disorders, EarlyView.
Abstract Background Very long chain fatty acids (VLCFAs) are an integral component of myelin and the epidermal water barrier. Variants in genes encoding enzymes responsible for catalyzing the first and rate limiting step in the production of VLCFAs, elongation of VLCFAs (ELOVLs), underlie a novel group of metabolic disorders. Objectives The goal was to
Keit Men Wong, Reza Maroofian, Kolja Meier, Susann Diegmann, Tinatin Tkemaladze, Javeria Raza Alvi, Behnoosh Tasharrofi, Stephanie Efthymiou, Alexander Munchau, G. Christoph Korenke, Naif Almontashiri, Wafaa Eyaid, Amna Kashgari, Modhi Alotaibi, Jutta Gärtner, Brenda Huppke, Mostafa Asadollahi, Gocha Chikvinidze, Mohammad Keramatipour, Tipu Sultan, Holger Thiele, Peter Nürnberg, Markus H. Gräler, Henry Houlden, Peter Huppke   +24 more
wiley   +1 more source

Aberrant outputs of glutamatergic neurons in deep cerebellar nuclei mediate dystonic movements. [PDF]

Sci Adv
Wu XM, Lu B, He JY, Zhang YX, Wu ZY, Xiong ZQ.   +5 more
europepmc   +1 more source

Disease‐Modifying Trials in Treated Parkinson's Disease: “Stable Treated” Does Not Equate with Biological Stability

Movement Disorders, EarlyView.
Abstract Traditionally, clinical trials of putative disease‐modifying therapies in Parkinson's disease have enrolled untreated patients at the earliest clinical stages of their disease. Due to a number of challenges inherent with this approach, there has been a recent move to a different study design, enrolling patients who are already taking “stable ...
M. Maral Mouradian, A. Jon Stoessl, Anthony E. Lang   +2 more
wiley   +1 more source

Comparing Injection Methods of Botulinum Toxin A for Cervical Dystonia: A Systematic Review. [PDF]

Life (Basel)
Shipkov H, Uchikov P, Imran A, Ul Hassan Z, Grozdev I, Kraev K, Kraeva M, Koleva N, Bozhkova M, Karamitev S.   +9 more
europepmc   +1 more source

Tremor Asymmetry and the Development of Bilateral Phase‐Specific Deep Brain Stimulation for Postural Tremor

Movement Disorders, EarlyView.
Abstract Background Tremor phase‐locked deep brain stimulation (DBS) has been shown to modulate symptom severity in postural tremor, including essential and dystonic tremor, with less energy than existing systems. Previous studies focused on unilateral stimulation; it remains unknown how tremor asymmetry interacts with stimulation in the context of ...
Shenghong He, Alceste Deli, Timothy O. West, Fernando R. Plazas, Alek Pogosyan, Christoph Wiest, Laura Wehmeyer, Fahd Baig, Francesca Morgante, Pablo Andrade, Michael G. Hart, James J. FitzGerald, Veerle Visser‐Vandewalle, Erlick A. Pereira, Alexander L. Green, Huiling Tan, Hayriye Cagnan   +16 more
wiley   +1 more source

Asenapine-induced severe dystonia in a patient with schizophrenia: medication error due to sound-alike drug. [PDF]

BMJ Case Rep
Wulff S, Nielsen J, Pedersen N, Nielsen MØ.   +3 more
europepmc   +1 more source